Trial intelligence / Profile preview

Up-and-down determination of the 95% effective dose of remifentanil to prevent coughing during extubation in pediatric tonsillectomy/adenoidectomy

KCT0000653Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Oct 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remifentanil in cough, sponsored by Seoul National University Hospital. Started Oct 2012; status: completed.

02

Drugs

remifentanil
03

Conditions

cough

Beyond the preview

Go deeper on KCT0000653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call